Understanding how RNA Pol II pausing affects male fertility
RNA Pol II Pausing is Critical for Spermatogenesis and Male Fertility
This study is looking at how a protein called TDP-43 helps control when genes are turned on during the development of sperm, which is really important for male fertility, and it hopes to find new ways to help men who are having trouble with infertility.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10438669 on NIH RePORTER |
What this research studies
This research investigates the role of RNA Polymerase II (Pol II) pausing in the process of spermatogenesis, which is crucial for male fertility. The study focuses on how the timing of gene expression is regulated during the development of sperm cells, as improper timing can lead to infertility. By examining the function of a specific protein, TDP-43, the research aims to uncover the mechanisms that ensure genes are expressed at the right time and place in germ cells. This could lead to new insights into male reproductive health and potential therapeutic targets for infertility.
Who could benefit from this research
Good fit: Ideal candidates for this research are men experiencing infertility issues related to spermatogenesis.
Not a fit: Patients with infertility due to non-genetic factors or those not experiencing issues with sperm development may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for male infertility by identifying key regulatory mechanisms involved in sperm development.
How similar studies have performed: While the specific focus on RNA Pol II pausing in spermatogenesis is novel, related research has shown success in understanding gene regulation in other contexts.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Reddi, Prabhakara P — University of Illinois at Urbana-Champaign
- Study coordinator: Reddi, Prabhakara P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.